Transfection of interleukin-12 cDNAs into tumor cells induces cytotoxic immune responses against native tumor: Implications for tumor vaccination

Cancer Gene Therapy

Volumn 5, Issue 3, 1998, Pages 150-157

  Hoshino, Taizo ^a   Jiang, Yin Zheng ^a   Dunn, Daniel ^a   Paul, Devchand ^b   Qazilbash, Muzaffar ^b   Cowan, Kenneth ^b   Wang, Jianxiang ^a   Barrett, John ^a   Liu, Johnson ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

2008 cells; CTL; Cytotoxicity; Interleukin 12; NK cells; Tumor immunotherapy

Indexed keywords

CANCER VACCINE; COMPLEMENTARY DNA; INTERLEUKIN 12;

ADENO ASSOCIATED VIRUS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE;

CANCER VACCINES; CYTOTOXICITY, IMMUNOLOGIC; DEPENDOVIRUS; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; HUMANS; INTERLEUKIN-12; LYMPHOCYTES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032067457     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med. 1989;170:827-845.
2. Stern AS, Podlaski FJ, Hulmes JD, et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA. 1990;87:6808-6812.
3. Wolf SF, Temple PA, Kobayashi M, et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991;146:3074-3081.
4. Scott P. IL-12: initiation cytokine for cell-mediated immunity. Science. 1993;260:496-497.
5. Brunda MJ, Gately MK. Antitumor activity of interleukin-12. Clin Immunol Immunopathol. 1994;71:253-255.
6. Lamont AG, Adorini L. IL-12: a key cytokine in immune regulation. Immunol Today. 1996;17:214-217.
7. Martinotti A, Stoppacciaro A, Vagliani M, et al. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. Eur J Immunol. 1995;25:137-146.
8. Brunda MJ, Luistro L, Warrier RR, et al. Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J Exp Med. 1993;178:1223-1230.
9. Tepper RJ, Mule JJ. Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther. 1994;5:153-164.
10. Jaffee EM, Dranoff G, Cohen LK, et al. High efficiency gene transfer into primary human tumor explants without cell selection. Cancer Res. 1993;53:2221-2226.
11. Vieweg J, Boczkowski D, Roberson KM, et al. Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer. Cancer Res. 1995;55:2366-2372.
12. Morgan RA, Couture L, Elroy-Stein O, Ragheb J, Moss B, Anderson WF. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res. 1992;20:1293-1299.
13. Qazilbash MH, Xiao X, Seth P, Cowan KH, Walsh CE. Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53. Gene Ther. 1997; 4:675-682.
14. + T lymphocytes can exert cytotoxicity to chronic myeloid leukaemia cells processing and presenting exogenous antigen. Brit J Haematol. 1996;93:606-612.
15. Tahara H, Lotze MT, Robbins PD, Zitvogel L. IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts. Hum Gene Ther. 1995; 6:1607-1624.
16. Yates JL, Warren N, Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature. 1985;313:812-815.
17. Adam MA, Ramesh N, Miller AD, Osborne WR. Internal initiation of translation in retroviral vectors carrying picornavirus 5′ nontranslated regions. J Virol. 1991;65:4985-4990.
18. Hayes MP, Jinhai W, Norcross MA. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood. 1995;86:646-650.
19. Klinman DM, Yi AK, Beaucage SL, Conver J, Krieg AM. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc Natl Acad Sci USA. 1996;93:2879-2883.
20. Gilboa E. Immunotherapy of cancer with genetically-modified tumor vaccines. Semin Oncol. 1996;23:101-107.
21. Son K, Huang L. Exposure of human ovarian carcinoma to cisplatin transiently sensitizes the tumor cells for liposome-mediated gene transfer. Proc Natl Acad Sci USA. 1994;91: 12669-12672.